Table 1.
Patient characteristics
| Anthracycline (n = 74) | S-1 (n = 80) | Total (n = 154) | |
|---|---|---|---|
| Age (years), median (IQR) | 60.5 (52–66) | 59.5 (49–64) | 60.0 (50–65) |
| Weight (kg), median (IQR) | 52.0 (48–59) | 53.0 (48–60) | 52.0 (48–60) |
| Performance status | |||
| 0 | 61 (82.4) | 64 (80.0) | 125 (81.2) |
| 1 | 13 (17.6) | 16 (20.0) | 29 (18.8) |
| Number of lymph node metastases | |||
| 0 | 24 (32.4) | 20 (25.0) | 44 (28.6) |
| 1–3 | 17 (23.0) | 27 (33.8) | 44 (28.6) |
| 4–9 | 11 (14.9) | 6 (7.5) | 17 (11.0) |
| > 9 | 5 (6.8) | 7 (8.8) | 12 (7.8) |
| Unknown | 17 (23.0) | 20 (25.0) | 37 (24.0) |
| Estrogen receptor | |||
| + | 56 (75.7) | 62 (77.5) | 118 (76.6) |
| − | 17 (23.0) | 11 (13.8) | 28 (18.2) |
| Unknown | 1 (1.4) | 7 (8.8) | 8 (5.2) |
| Progesterone receptor | |||
| + | 45 (60.8) | 52 (65.0) | 97 (63.0) |
| − | 26 (35.1) | 21 (26.3) | 47 (30.5) |
| Unknown | 3 (4.1) | 7 (8.8) | 10 (6.5) |
| History of surgery | |||
| No | 18 (24.3) | 18 (22.5) | 36 (23.4) |
| Yes | 56 (75.7) | 62 (77.5) | 118 (76.6) |
| History of chemotherapy | |||
| No | 49 (66.2) | 57 (71.3) | 106 (68.8) |
| Yes | 25 (33.8) | 23 (28.8) | 48 (31.2) |
| History of oral fluorouracil | |||
| No | 63 (85.1) | 69 (86.3) | 132 (85.7) |
| Yes | 11 (14.9) | 11 (13.8) | 22 (14.3) |
Data represent n (%) unless stated otherwise. IQR inter quartile range